FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071658 [Registered on: 31/07/2024] Trial Registered Prospectively
Last Modified On: 31/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Administering fluids in advance to prevent low blood pressure in patients undergoing surgery with spinal anesthesia. 
Scientific Title of Study   Effect of inferior vena cava collapsibility index guided fluid optimization on incidence of hypotension after subarachnoid block in patient undergoing infraumbilical surgeries. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sumit Kumar 
Designation  Post graduate resident  
Affiliation  Vardhman Mahavir Medical College and Safdarjung hospital 
Address  Department of Anaesthesia and Intensive care, Vardhman Mahavir Medical College and Safdarjung hospital, Ansari Dagar, New Delhi New Delhi Delhi 110029 India

New Delhi
DELHI
110029
India 
Phone  7683078340  
Fax    
Email  sumitchoudhary4383@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amita Gupta 
Designation  Professor and Consultant  
Affiliation  Vardhman Mahavir Medical College and Safdarjung hospital 
Address  Department of Anaesthesia and Intensive care, Vardhman Mahavir Medical College and Safdarjung hospital, Ansari Dagar, New Delhi New Delhi Delhi 110029 India

New Delhi
DELHI
110029
India 
Phone  9910382190  
Fax    
Email  amitaguptadr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Amita Gupta 
Designation  Professor and Consultant  
Affiliation  Vardhman Mahavir Medical College and Safdarjung hospital 
Address  Department of Anaesthesia and Intensive care, Vardhman Mahavir Medical College and Safdarjung hospital, Ansari Dagar, New Delhi New Delhi Delhi 110029 India

New Delhi
DELHI
110029
India 
Phone  9910382190  
Fax    
Email  amitaguptadr@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sumit Kumar  Vardhman Mahavir Medical College and Safdurjung Hospital   Department of anaesthesia, Main OT building, Room no 3, division 1, Ground floor ,vardhman Mahavir Medical College and Safdurjung Hospital, Ansari Nagar, New Delhi
New Delhi
DELHI 
7683078340

sumitchoudhary4383@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of VMMC and Safdarjung hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K40-K46||Hernia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  IV fluid boluses of normal saline  Fluid boluses of normal saline will be given at 5ml/kg over 15 minutes. 
Comparator Agent  No fluid boluses  Fluid boluses of normal saline at 5ml/kg over 15 minutes will not be given  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  ASA physical status 1 or 2 undergoing elective infraumblical and lower limb surgery  
 
ExclusionCriteria 
Details  1.Contraindications for subarachnoid block
2.Pregnancy
3.Body Mass Index more than 30 kg per meter square 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the incidence of hypotension after subarachnoid block using inferior vena cava collapsibility index guided volume optimization in patients undergoing infraumbilical surgeries   Every 5 minutes till 30 minutes  
 
Secondary Outcome  
Outcome  TimePoints 
1.Number of fluid boluses required in preoperative room.
2.The total amount of IV fluid required in both the groups.
3.Total dose of mephentermine used in both the groups.
4.Total number of patients who had episode of bradycardia in both the groups. 
Every 5 minutes till 30 minutes  
 
Target Sample Size   Total Sample Size="92"
Sample Size from India="92" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study is prospective comparative study to assess the incidence of hypotension after subarachnoid block using inferior vena cava collapsibility index guided volume optimization in patients undergoing infraumbilical surgeries. Inferior vena cava collapsibility index will be measured using USG. If Inferior vena cava collapsibility index will be more than 3 percent, then patient will receive Fluid boluses and repeat IVC USG will be done and fluid boluses will be given accordingly till IVC CI become less than 35 percent. Sensory block and motor block will be assessed every 5 min with strict vital monitoring will be done. The variables observed are total amount of fluid given in both the group, number of patients who developed hypotension in both the groups and the number of patients developing bradycardia.
 
Close